Company profile

CorVista Health, Inc.

CorVista Health, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on September 8, 2023 and the most recent on September 8, 2023 (CorVista® System). Its most common review panel is Cardiovascular (1 device).

1AI devices
2023First decision
2023Latest decision
1Specialties

Timeline

  1. CorVista® System · Cardiovascular · QXX